OrbiMed Capital GP III LLC, 10% Owner at PIERIS PHARMACEUTICALS, INC. (PIRS), sold 15,719 shares at $8.98 ($141K) on 2018-02-13, disclosed to the SEC on 2018-02-15.
Open-market sale of $141k PIRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.98 | 75 | $674 | 0.5% |
| 2 | $8.98 | 7,822 | $70K | 49.8% |
| 3 | $8.98 | 7,822 | $70K | 49.8% |
| Total | $8.98 avg | 15,719 | $141K | 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |
| ROKA | SELL | 2017-10-05 | $273K | — | Filing → |